...
首页> 外文期刊>ACS Chemical Biology >Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPAR delta-RXR
【24h】

Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPAR delta-RXR

机译:自然产品启发的RXR激动剂的发现和SAR对PPAR DELTA-RXR的异二聚体选择性

获取原文
获取原文并翻译 | 示例
           

摘要

A known natural product, magnaldehyde B, was identified as an agonist of retinoid X receptor (RXR) alpha. Magnaldehyde B was isolated from Magnolia obovata (Magnoliaceae) and synthesized along with more potent analogs for screening of their RXR alpha agonistic activities. Structural optimization of magnaldehyde B resulted in the development of a candidate molecule that displayed a 440-fold increase in potency. Receptor-ligand docking simulations indicated that this molecule has the highest affinity with the ligand binding domain of RXR alpha among the analogs synthesized in this study. Furthermore, the selective activation of the peroxisome proliferator-activated receptor (PPAR) delta-RXR heterodimer with a stronger efficacy compared to those of PPAR alpha-RXR and PPAR gamma-RXR was achieved in luciferase reporter assays using the PPAR response element driven reporter (PPRE-Luc). The PPAR delta activity of the molecule was significantly inhibited by the antagonists of both RXR and PPAR delta, whereas the activity of GWS01516 was not affected by the RXR antagonist. Furthermore, the molecule exhibited a particularly weak PPAR delta agonistic activity in reporter gene assays using the Gal4 hybrid system. The obtained data therefore suggest that the weak PPAR delta agonistic activity of the optimized molecule is synergistically enhanced by its own RXR agonistic activity, indicating the potent agonistic activity of the PPAR delta-RXR heterodimer.
机译:已知的天然产物Magnaldehyde B被鉴定为类视黄醇X受体(RXR)α的激动剂。 Magnaldehyde B从Magnolia Obovata(Magnoliaceae)中分离,并与更多的有效类似物合成,用于筛选其RXR alpha激动活动。 Magnaldehyde B的结构优化导致候选分子的发展显示出440倍的效力增加。受体 - 配体对接模拟表明该分子具有与本研究合成的类似物中RXRα的配体结合结构域的亲和力。此外,使用PPAR响应元件驱动的报告者,在荧光素酶报告分析中获得了与PPARα-RXR和PPARγ-RXR的效果相比的过氧化物体增殖物激活的受体(PPAR)Delta-RXR异二聚体的选择性活化。 ppre-luc)。通过RXR和PPAR三角洲的拮抗剂显着抑制分子的PPARδ活性,而GWS01516的活性不受RXR拮抗剂的影响。此外,使用GAL4杂交系统,分子在报告基因测定中表现出特别弱的PPARδ激动活性。因此,所获得的数据表明优化分子的弱PPARδ激酶活性通过其自身的RXR激动活性来协同增强,表明PPAR Delta-RXR异二聚体的有效激动活性。

著录项

  • 来源
    《ACS Chemical Biology》 |2020年第6期|共9页
  • 作者单位

    Aichi Gakuin Univ Sch Pharm Lab Med Resources Nagoya Aichi 4648650 Japan;

    Gifu Pharmaceut Univ Lab Pharmaceut Synthet Chem Gifu 5011196 Japan;

    Aichi Gakuin Univ Sch Pharm Lab Med Resources Nagoya Aichi 4648650 Japan;

    Gifu Pharmaceut Univ Lab Pharmaceut Synthet Chem Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Pharmaceut Synthet Chem Gifu 5011196 Japan;

    Aichi Gakuin Univ Sch Pharm Lab Med Resources Nagoya Aichi 4648650 Japan;

    Gifu Pharmaceut Univ Lab Pharmacognosy Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Herbal Garden Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Pharmacognosy Gifu 5011196 Japan;

    Gifu Pharmaceut Univ Lab Pharmaceut Synthet Chem Gifu 5011196 Japan;

    Aichi Gakuin Univ Sch Pharm Lab Med Resources Nagoya Aichi 4648650 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号